NCT03917940View on ClinicalTrials.gov

Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

May 1, 2020

Study Completion Date

May 10, 2020

Conditions
Diabetic Patients
Interventions
DIETARY_SUPPLEMENT

Omega 3 fatty acids 1000 mg per day + glimepiride 2 mg or 3 mg oral

Omega 3 fatty acids 1000 mg per day oral

DRUG

Glimepiride

glimepiride 2 mg or 3 mg per day oral

Trial Locations (1)

31527

Damanhour Medical National Institute, Damanhūr

All Listed Sponsors
lead

Damanhour University

OTHER

NCT03917940 - Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride | Biotech Hunter | Biotech Hunter